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Abstract: Background: Compared to other chronic conditions, non-adherence to 
medication in diabetes patients is very high. This study explores the relationship 
between illness representation and medication adherence in diabetes patients 
in Ghana. Method: A total of 196 type 2 diabetes patients purposively and conve-
niently sampled from a tertiary hospital in Ghana responded to the Revised Illness 
Perception Questionnaire (IPQ-R) and the Medication Adherence Report Scale 
(MARS-5). The Pearson Moment Product correlation and the hierarchical multiple re-
gression statistical tools were used to analyse the data. Results: Illness consequence 
and emotional representation were negatively related to medication adherence, 
while personal control positively accounted for significant variance in medication 
adherence. However, none of the selected key demographic variables (i.e. age, ill-
ness duration, gender, religion and education) independently accounted for any 
significant variance in medication adherence. Conclusion: Diabetes has a telling 
consequence on patients’ life; the patient can do something to control diabetes; and 
the negative emotional representations concerning the disease have a significant 
influence on the degree of medication adherence by the patients. This observation 
has implications for the management and treatment plan of diabetes.
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ABOUT THE AUTHORS
We have come to appreciate that health is a 
function of context, which is not just about the 
relevant background of health, but a dynamic 
element that sets the tone for the course of health 
in general. we are interested in psychological 
factors which affect the course and management 
of chronic diseases in under-served, low and-
middle income communities where chronic 
diseases are trivialized and less prioritized. 
There are also various commonly held negative 
perceptions about chronic illnesses which hinder 
the successful management and prevention 
chronic illnesses. We believe research (like the 
present one) is the first step to understanding and 
undoing these negative perceptions and attitudes 
held by patients of chronic illnesses.
PUBLIC INTEREST STATEMENT
People with chronic conditions that present with 
(seemingly) no or less symptoms are often found 
not to adhere to their prescribed medication for 
disease control. Past research has indicated that 
the beliefs and expectations that people hold 
do translate into the actions that they take. The 
purpose of this study was to explore if the beliefs 
and expectations that diabetes patients hold 
concerning the disease influence their medication 
adherence behaviour. Data on patients’ beliefs 
and expectation and medication adherence were 
gathered from 196 diabetes patients using self-
report structured questionnaire. The results of the 
analysis showed that patients’ beliefs about the 
control they have over the disease, their expected 
consequences of the disease, and the emotional 
responses they have in relation to the disease 
were independently related to their medication 
adherence behaviour. This result has implications 
for the management and treatment plan for the 
disease.
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1. Introduction
Diabetes mellitus is one of the most common chronic diseases in most countries with a continuous 
increase in numbers in terms of incidence and prevalence. According to International Diabetes 
Federation (IDF) 2015 report, 1 in 11 adults have diabetes (415 million) worldwide. Again there were 
266,200 cases of diabetes recorded in Ghana in 2015 with a prevalence rate of 1.9% in adults aged 
20–79 years (IDF, 2015). Currently, majority of the people living with diabetes are found to be living 
in low- and middle-income countries and are expected to experience the greatest increase in cases 
of diabetes over the next 22 years (Guariguata et al., 2014). In terms of age and regional distribution 
of the disease burden of diabetes, persons within the 40–59 years bracket are the most affected with 
the highest proportion (61%) of the burden recorded in the Africa region and 67% in low-income 
countries (Guariguata et al., 2014). It is indicative from the statistics that diabetes poses a serious 
health threat to developing countries as the region bears the greater proportion of the disease 
burden.
Usually symptoms of diabetes are not severe, or may be absent (American Diabetes Association, 
2010). Hence, hyperglycemia (abnormal high blood sugar level) may be present for a long time caus-
ing pathological and functional changes before a diagnosis is made or mismanagement after diag-
nosis (Arkkila & Gautier, 2003). The effects of hyperglycemia have been documented as regard 
long-term damage and failure of various organs including potential blindness (WHO, 2014), renal 
failure (Suissa, Hutchinson, Brophy, & Kezouh, 2006). However, long-term glycemic (blood sugar 
level) control has also been established as being fundamental to the management of diabetes and 
has been shown to reduce both microvascular and macrovascular complications (Asche, LaFleur, & 
Conner, 2011).
Healthy lifestyle choices including diet, exercise and weight control provide the foundation for 
managing diabetes but some patients in addition may need medication to achieve targeted blood 
sugar levels (Nathan et al., 2009). Nevertheless, despite adequate diagnosis and medical care, most 
patients often fail to derive the optimal clinical benefit of drug therapy because of medication non-
adherence posing a pervasive clinical challenge (Rozenfeld, Hunt, Plauschinat, & Wong, 2008; Simoni, 
Frick, & Huang, 2006; Yu, Yu, & Nichol, 2010). However, among diabetes patients non-adherence is 
reported to be very high compared with other chronic conditions (Cramer, 2004; DiMatteo, 2004; 
Jambedu, 2006; Mann, Ponieman, Leventhal, & Halm, 2009).
In Ghana, adherence to anti-diabetic medication by patients is estimated to be low with the re-
ported rate ranging between 40 and 50% (Jambedu, 2006).The implication is that, owing to the non-
adherence, many diabetes patients are at higher risk of both acute and chronic complications. These 
complications may lead to higher need for hospitalization, additional health cost as well as increased 
levels of morbidity (Deshpande, Harris-Hayes, & Schootman, 2008). Research exploring illness prac-
tices among diabetes patients in Ghana identifies that diabetes patients rated biomedical manage-
ment as the ideal and preferred practice. However they were constrained due to the psychosocial 
impact of the disease (specifically, daily drug and dietary management routines) and the high cost 
involved. As such there was a drive among diabetes patients for other practices such as cure seeking 
and medical inaction (Aikins, 2005). Again, it has been found in a study from Ghana that health is 
conceptualized as strength and so when their wellbeing and ability to engage in everyday practices 
are altered due to some form of medication they are taking, they are unlikely to continue taking the 
medication even though it helps in managing a diagnosed condition (Read, 2012).
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In explaining health behaviors, psychosocial determinants are increasingly identified as impacting 
health and treatment (Sallis, Owen, & Fisher, 2008). A number of reasons has been given to the vari-
ations in patients’ beliefs and treatment adherence among patients (Catz, Kelly, Bogart, Benotsch, & 
McAuliffe, 2000; Vermeire, Hearnshaw, Van Royen, & Denekens, 2001). The patients’ beliefs based 
theory by Leventhal, Meyer, and Nerenz (1980)—self-regulatory model (SRM) of Illness 
Representation—has been found to help predict health behaviours and outcomes in patients of 
chronic illnesses.
The self-regulation model of illness representation (Leventhal et al., 1980) introduces a patient-
centered understanding to the dynamic factors which influence health behaviours including medica-
tion adherence. Central to this model is beliefs and expectations that patients hold concerning their 
illness. The model suggests that, individuals, in order to understand and cope with their illness, try to 
make sense of their illness by developing a working framework of what their illness is, which in turn 
influences actions that are taken in response to the illness. The patients thus use these beliefs and 
expectations in interpreting the illness or to make sense of the associated somatic symptoms, decid-
ing on a response, and evaluating the appropriateness of the response (Cameron & Leventhal, 2003).
The SRM model suggests that, although a patient’s behaviour may not necessarily be medically 
rational, their health responses are usually informed mostly by their beliefs and expectations con-
cerning the illness (Reynolds, 2003). These representations are however said to vary across diseases 
and are formed through personally experienced symptoms and information through social and cul-
tural channels (Hirani & Newman, 2005; Hagger & Orbell, 2003). Therefore research findings related 
to illness representation in a particular illness condition or setting may be different from other illness 
groups as well as different cultural settings.
Research on chronic conditions has found that illness representations account for a significant 
variance in the diversity within disease-related functioning (Hirani & Newman, 2005; Horne & 
Weinman, 2002; MacInnes, 2013; Petrie, Weinman, Sharpe, & Buckley, 1996). Jacobs, Kemppainen, 
Taylor, and Hadsell (2014) assessed personal beliefs about the causes and meaning of having diabe-
tes among the members of the Lumbee Indian tribe living in rural southeastern North Carolina. The 
findings indicated that higher scores on the consequence and emotional representation were asso-
ciated with higher adherence to medication. However, no significant age and gender differences 
were found. Similarly, Ross, Walker, and MacLeod (2004) observed among hypertensive patients that 
emotional representation was negatively associated with compliance with medication, whereas 
lower consequence, lower personal control beliefs, and high-treatment control beliefs were found to 
be associated with high compliance with medication. Also Mosleh and Almalik (2016) explored simi-
lar concepts in a study among coronary heart disease patients in Jordan. The study showed personal 
and treatment control as independent predictors of medication adherence among coronary heart 
disease patients.
Therefore, evidence from previous studies demonstrates that there is no unitary representation 
for all illnesses due to differences in illness experience and differences in the cultural and social 
context within which a disease is experienced. It can be deduced from the foregoing reviewed litera-
ture that even though patient’s adherence to anti-diabetic medication has been found to be disturb-
ingly low in Ghana (Jambedu, 2006), and the illness practices of patients have generally not received 
enough research attention, studies exploring diabetes patients’ own representation of the illness 
and how this influences medication adherence in particular is lacking. Thus, this study seeks to ad-
dress this knowledge gap by quantitatively exploring the relationship between illness representation 
and medication adherence among diabetes patients in Ghana. Specifically, this study sets out to 
explore:
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(1)  The components of illness representation that significantly predict medication adherence in 
diabetes patients.
(2)  The key demographic variables (i.e. age, education, gender, religious affiliation, duration of 
illness) which significantly predict medication adherence among diabetes patients.
2. Methods
2.1. Research setting
According to Guariguata et al. (2014), the current annual prevalence rate of diabetes is 3.4% affect-
ing persons aged between 20 and 79 years in Ghana. However, the crude prevalence of diabetes in 
a study by Amoah, Owusu, and Adjei (2002) in Accra (the site for this study), the capital city of 
Ghana, was reported to be 6.3%, indicating a comparatively higher prevalence rate than the national 
rate.
2.2. Participants
One hundred and ninety-six diabetes patients were purposively and conveniently sampled from the 
out-patient unit of a tertiary hospital in the Greater Accra region of Ghana. This sample size was 
deemed adequate based on the statistical test proposed for the study—regression analysis for test-
ing a medium size effect with a power of 80%. According to Tabachnick and Fidell (2007), to test an 
overall regression model a sample size of 50 + 8(K) is needed, where K is the number of predictors 
and so the needed sample size was 149 minimum. Again, to test independent predictors, a sample 
size of 104 + K is needed, which is less than 196 recruited for our study. Participants included in the 
present study had been on oral anti-diabetic medication since at least the past six months preceding 
the study. The sample consisted of 80 males and 116 females, all aged between 25 and 90 years old 
with a mean age of 59.8 (SD = 11.97) years. The number of years that participants had lived with dia-
betes ranged from 1 year to 40 years with a mean duration of 9.58 (SD = 8.02) years. Other demo-
graphic characteristics of the sample are shown in Table 1. Participants were included if they were 
18 years of age or above, have been on anti-diabetic medications for not less than six months, and 
consent to participate in the study.
2.3. Measures
The participants responded to two self-report standardised scales: the illness perception question-
naire-revised (IPQ-R), and the medication adherence report scale (MARS-5). IPQ-R was employed to 
measure illness representation, whereas MARS-5 was used to assess the patients’ medication adher-
ence behaviour. The IPQ-R was developed to measure and assess patients’ beliefs and expectations 
about their illness (Moss-Morris et al., 2002; Weinman,  Petrie,  Moss-Morris, & Horne, 1996). The IPQ-R 
has 71 items divided into 12 subscales with responses on a Likert format ranging from 1 (strongly disa-
gree) to 5 (strongly disagree). However, in the present study, five of the subscales were not used due 
to the constraints of the cross-sectional design employed. Thus, seven subscales were used in the 
present study: treatment control which measures an individual’s believe in the ability of their diabetic 
medication to control the disease made up of five items (e.g. my treatment will be effective in curing 
my diabetes); personal control which measures the individuals believe in their ability to alter the course 
Table 1. Demographic data of sample
Variable n %
Gender Females 80 40.8
Males 116 59.2
Religious affiliation Christian 175 89.3
Muslim 21 10.7
Educational background Low 62 31.6
Middle 73 37.2
High 61 31.1
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of their illness made up of six items (e.g. There is a lot which I can do to control my diabetes); conse-
quence which constitutes the individuals appraised impact of their illness on their life, made up of six 
items (e.g. My diabetes is a serious condition); timeline cyclical which assesses the individuals under-
standing of the nature of their symptoms of their illness measured with four items (e.g. My diabetes 
symptoms come and go in cycles); timeline acute/chronic measures the individual’s believe in whether 
their illness will be for a while or forever, made up of six items (e.g. My diabetes will last a short time); 
illness coherence which assesses the individual’s perceived understanding of what their illness is, 
which is made up of five items (e.g. I don’t understand my diabetes) and emotional representation 
measuring the emotions that are experienced when one thinks about their illness, also made up of six 
items (e.g. When I think about my diabetes I get upset). These components showed good test-retest 
reliability in other studies, with correlations ranging from .46 to .88 and internal reliability or Cronbach’s 
alphas for the original English version of IPQ-R ranging from .79 to .89 for the subscales (Moss-Morris 
et al., 2002).The current study recorded Cronbach’s alphas ranging between .71 and .92.
The MARS-5 (Horne & Hankins, 2004) is a 5-item self-report measure for the assessment of medi-
cation adherence (or non-adherent) behaviour. It has a 5-point Likert scale response format, ranging 
from 1(very often) to 5 (never). Examples of items on the scale include “I alter my dose”, “I use my 
medication less than is prescribed” etc. A lower score on the scale indicates lower levels of adherent 
behaviour to medication. Cronbach’s alpha for MARS-5 reported by Bäck, Sundell, Horne, Landén, 
and Mårdby (2012) was .66. The Cronbach’s alpha of MARS-5 for this study was .86.
The participants also reported on their age, sex, religious affiliation, number of years lived with the 
disease and their level of education. However, the questionnaire was anonymous in that it contained 
no item eliciting personal or identifiable information from participants (e.g. names, date of birth, 
postal or residential address, telephone number etc.).
2.4. Procedure
The study received ethical approval from the University of Ghana Ethics Committee for the Humanities 
(ethical clearance code: ECH 067/14-16). Permission was sought from the Ghana Health Service and 
the administration of the selected hospital for the study. Potential participants were walked through 
the purpose and general information about the study at the out-patient department where patients 
were waiting to see medical professionals for medication fill-up. Interested patients signed a con-
sent form prior to participation. The questionnaires were administered individually by the research-
ers to the participants in a conference room designated for the study. To further strengthen 
anonymity and confidentiality, the sitting arrangement was spaced far apart such that a participant 
could not see the responses of others.
2.5. Statistical analysis
The data was analyzed using the statistical package for social sciences (SPSS, version 21). Prior to 
conducting the main analyses, the data were screened for statistical outliers (scores on key variables 
_ 3 SD from the mean). Next, correlation analyses were conducted to examine the bivariate associa-
tions among the study variables. Following this, variables with significant correlations were included 
in a hierarchical multiple regression analysis to test whether illness representation variables pre-
dicted medication adherence whist controlling for the effects of demographic variables.
3. Results
3.1. Relationship between study variables
The correlations among the illness representation subscales, demographic variables and medication 
adherence are presented in Table 2.
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Higher illness consequence [r = −.50, p < .01] and negative emotional representation [r = −.43, 
p < .01] were negatively correlated with medication adherence. However, higher personal control 
[r = .60, p < .01] and treatment control [r = .14, p < .05] beliefs were positively correlated with medi-
cation adherence. The dimensions of illness coherence [r = −.03, p > .05] and disease timeline chro-
nicity [r = −.18, p > .05] and timeline cyclical [r = −.01, p < .05] were not significantly correlated with 
medication adherence.
3.2. Predictors of medication adherence
The overall regression model predicting medication adherence from patient demographic variables 
and illness representation components using a hierarchical multiple regression was significant 
[R2 = .516, F (12,183) = 16.25, ρ < .01] explaining about 51.6% of variance in the level of medication 
adherence among this sample (see Table 3).
From the Table 3, in step 1, where the demographic variables were entered, the regression model 
was not significant [R2 = .014, ρ = .05, step 1]. Thus, generally, all the demographic variables did not 
independently account for any significant variance in medication adherence. In step 2 of Table 3, 
illness representation components were entered, and this yielded a significant regression model 
[ΔR2 = .502, ρ < .01, step 2]. Thus, all the illness representation components in general accounted 
Table 2. Pearson moment product correlation matrix among the study variables
*p < .05
**p < .01.
Variable 1 2 3 4 5 6 7 8
1. Acute/chronic –
2. Cyclical −.19 –
3. Personal control −.31** −.04 –
4. Consequence .27** .15 −.41** –
5. Emotional control .01 .25** −.31** .37** –
6. Treatment control −.48** −.06 .44** −19** −.07 –
7. Illness coherence .16 −.64** .06 −.06 −.25** .16* –
8. Adherence −.18 −.01 .60** −.50** −.43** .14* −.03 –
Table 3. Hierarchical multiple regression of Medication adherence
Note: R2 = .02, (p > .05) for Step 1; ΔR2 = .502, (p < .01) for Step 2; **p < .01 alpha level.
Predictors B SEB β t p ΔR2
Model 1 .014
Age .01 .01 .06 .96 .33
Illness duration .03 .02 .09 1.55 .12
Gender .25 .34 .04 .74 .45
Religion .22 .45 .03 .48 .63
Education .26 .30 .05 .89 .38
Model 2 .502**
Acute −.01 .04 −.01 −.16 .88
Cyclical .04 .09 .03 .43 .67
Personal control .47 .06 .48 7.85 .00**
Consequence −.23 .05 −.29 −4.67 .00**
Emotional representation −.10 .03 −.21 −3.52 .00**
Treatment control −.11 .07 −.10 −1.52 .12
Illness coherence −.08 .05 −.11 −1.58 .12
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50.2% of the variance in medication adherence. As shown in Table 2, the illness representation com-
ponents that were independently related to medication adherence in this sample were representa-
tion of personal control [β = .48, t = 7.58, ρ < .01]; representation of consequence [β = −.29, t = −.4.67, 
ρ < .01]; and emotional representation of the illness [β = −.21, t = −3.52, ρ < .01].
4. Discussion
This study set out to investigate whether illness representation and patient demographics are pre-
dictors of medication adherence among diabetes patients in Ghana using a sample of 196 diabetes 
patients from a tertiary Hospital in the Greater Accra Region. The findings indicated that, none of the 
patient demographic variables measured (i.e. age, gender, religion, educational background and 
duration living with the illness) was significantly related to medication adherence. The illness repre-
sentation component of the personal control subscale was independently and positively related to 
medication adherence, whilst illness consequence and emotional representation were independent 
negative correlates of medication adherence.
Thus demographic variables (age, gender, religion, educational background and illness duration) 
did not predict a significant variance in medication adherence. This finding is consistent with the evi-
dence by Jacobs et al. (2014) who found no significant differences for age (over or less than 50 years) 
or gender among a sample of diabetes patients in India. Horne and Weiman (2002) found that, so-
cio-demographic and clinical factors explained only a small amount of variance in adherence. As 
such categorising or targeting demographic variables for interventions may not be beneficial to dia-
betes patients.
Drawing on these findings, overall, the components of illness representation with significant inde-
pendent relationship with medication adherence are personal control, illness consequence and emo-
tional representation. In other words, diabetes patients who believe that they can personally engage 
in activities to alter the course of their illness are likely to adhere to their prescribed medication. 
However, patients who believe diabetes has serious negative impacts on their lives and represent it 
with negative emotions are less likely to adhere to their prescribed medication. This current finding 
is consistent with some previous studies, however, the variables vary as to which of the components 
positively or negatively predicted medication adherence. For instance, in the study by Jacobs et al. 
(2014) from Indian, the findings indicated that higher scores on the consequence and emotional 
representation were associated with higher adherence to medication. However, in a similar study by 
Ross et al. (2004) emotional representation was negatively associated with compliance with medi-
cation while lower consequence, lower personal control beliefs, and high-treatment control beliefs 
were associated with higher compliance. Also, Mosleh and Almalik (2016) found that personal and 
treatment control were positive independent predictors of medication adherence. The findings of 
the present study suggest that having higher beliefs of negative illness consequence, the represen-
tation of the disease with negative emotions, and the belief that one can alter the course of the 
disease through their own initiatives positively predicted medication adherence.
This could be explained with the learned helplessness theory (Maier & Seligman, 1976) which sug-
gests that individuals who experience severe stressful situations over a period of time in turn learn 
that nothing can be done about their condition and thus give up trying to deal with the situation. As 
regard low medication adherence observed in this study, it can be argued that, people who experi-
ence negative diabetes consequences over a long period of time tend to adhere less to their pre-
scribed medication plausibly because they tend to subscribe to the false belief that the impact of 
diabetes on their lives will persist for a lifetime regardless of medication adherence. Also studies 
exploring illness practices in Ghana among patients living with diabetes have identified that al-
though most patients rate biomedical management as the preferred practice, they are constrained 
due to the psychosocial impact of the disease, hence driving them to other practices such as cure 
seeking and medical inaction (Aikins, 2005). Likewise, when patients perceive that taking their medi-
cation will alter their state of wellbeing with some form of side effect from the medication that can 
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alter their daily living, the patients are unlikely to continue taking the medication even though medi-
cation helps in managing the diagnosed condition (Read, 2012).
Finally, it is evident from this study that, personal control belief is positively related to medication 
adherence. This means that, patients with the belief that they are able to do something to alter the 
course of their chronic health condition are more likely to adhere to their prescribed medication. 
Rozema, Völlink, and Lechner (2009) found that personal control had a significant positive relation-
ship with problem-focused coping. Medication adherence in this study can be described as a form of 
problem-focused coping where patients take active measures to control their diabetes.This finding 
is consistent with the theory of planned behaviour which supposes that perceived behavioral control 
has a direct influence on intention, and that for desirable behaviours, greater perceived behavioral 
control is needed (Kraft, Rise, Sutton, & Røysamb, 2005).
5. Research implication
The study has some implications for healthcare delivery to diabetes patients by health professionals 
providing care. The findings of the study give support to the fact that a patient’s cognitive and emo-
tional appraisal of their chronic illness is important in the management of chronic illness. The study 
implies that patients have their own beliefs and expectations about their condition, aside what they 
are told by health professionals. The health beliefs and expectations held by patients have been 
shown to relate to the rate at which they adhere to their prescribed medication as well as their level 
of psychological distress. The evidence from this study further implies that key attention should be 
paid by health professionals to the representation of diabetes by patients, as previous evidence 
shows that patients’ illness representation significantly relates to the level of medication adherence. 
The results of the current study show that, diabetes patients, who doubt their ability to control their 
illness, represent higher disease consequence and hold higher levels of negative emotions about the 
disease are less likely to adhere to their recommended medications. Interventions should thus be 
directed at empowering patients to take maximum control over their illness believing that their ac-
tions could improve their condition above their disease consequence expectations. It is thus impera-
tive for health professionals to be holistic in their approach to healthcare by taking into consideration 
the importance of the patients’ representation of the disease, while providing care for diabetes 
patients.
6. Limitations
A notable shortcoming of the present study which should guide the interpretation and conclusions 
drawn relates to the inability of the study to adequately explore all potential (and contextually rel-
evant) factors which could be related to medication adherence in diabetes patients in Ghana (age, 
sex, duration since diagnoses, religious affiliation, etc.). Given the paucity of studies on medication 
adherence among diabetes patients in low and-middle-income countries, including Ghana, future 
studies may consider the use of qualitative approaches to explore other factors and contextually 
relevant variables (e.g. medication affordability, spirituality, side effect of medication etc.) which 
may influence patient behaviour in terms of diabetes medication adherence. Another plausible limi-
tation is the sample source and characteristics. The participants in this study were selected from one 
hospital, limiting the generalizability of the findings. Again, the study used diabetes patients who 
could communicate in the English language thereby excluding non-English speaking participants 
who could have otherwise provided other potentially interesting responses. Finally, the cross-sec-
tional design precluded establishing causal relationship between living with diabetes and, medica-
tion adherence and illness representation variables.
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